Zimmer Biomet Holdings Inc (NYSE:ZBH) was identified as a strong dividend candidate by our stock screener. The company combines a solid dividend track record with decent profitability and financial health, making it an interesting option for income-focused investors.
Dividend Strength
Consistent Payouts: ZBH has paid dividends for at least 10 years without reductions, demonstrating reliability.
Sustainable Payout Ratio: Only 21.28% of earnings are allocated to dividends, leaving room for future growth.
Modest Yield: The current yield of 1.01% is below the S&P 500 average but competitive within its industry, outperforming 93.65% of peers.
Profitability Highlights
Strong Margins: ZBH boasts an operating margin of 19.59%, ranking in the top 7% of its sector.
Healthy Returns: Its return on equity (7.37%) and return on invested capital (5.99%) are above industry averages.
Positive Cash Flow: The company has maintained positive operating cash flow over the past five years.
Financial Health Considerations
Debt Management: While ZBH carries a moderate debt load (Debt/Equity of 0.53), its liquidity remains stable with a current ratio of 2.44.
Solvency Concerns: The Altman-Z score (2.62) suggests some risk, though still better than 66.67% of industry peers.
For a deeper dive into ZBH’s fundamentals, review the full report here.
This is not investing advice! The article highlights observations at the time of writing, but you should conduct your own analysis before making investment decisions.